PM360
APRIL 25, 2023
Humira has evolved significantly since first launching in 2003 to include new concentrations, citrate-free versions, latex-free delivery devices, and smaller needle gauges, and each of the adalimumab biosimilars varies slightly with its approved product attributes. 2022 was a fascinating year for biosimilars, but may prove dull to 2023.
pharmaphorum
NOVEMBER 9, 2022
The keynote address of the event entire came from Stella Kyriakides, commissioner for health and food safety at the European Commission. In September, the EU launched its recommendations on cancer screening, updated for the first time since 2003. Collaborating and committing to innovation, equity, and cancer care across Europe.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
FEBRUARY 3, 2023
A partial change in perspectives The RV144 trial that took place between 2003 and 2006 in Thailand r eported modest efficacy results , which generated enthusiasm for vaccines that induce responses from non-neutralising antibodies, says Montefiori. The third cohort features the highest studied dose.
European Pharmaceutical Review
MARCH 11, 2024
With therapeutic expertise in HIV, hepatology and rare diseases, Sherene has additional expertise in clinical pharmacology and drug safety. Sherene has worked in the healthcare sector for more than 20 years, including in several leadership roles at GSK. References 1. World Health Organization. The Global Health Observatory. Internet] 2023.
Nixon Gwilt Law
NOVEMBER 10, 2022
North Dakota State University conducted a study in 2002, known as the North Dakota Telepharmacy Project, to evaluate the safety and efficacy of telepharmacy and found that it [telepharmacy] was as safe or safer than other forms of traditional pharmacy services.
PM360
JUNE 11, 2022
When rosuvastatin entered the statin market in 2003, it faced the daunting challenge of competing against behemoths atorvastatin and simvastatin. Some of this urgency is inherent to the industry. It also faced negative press when The Lancet published an editorial condemning the quality of its clinical trials.
European Pharmaceutical Review
JULY 20, 2023
Covered SoHO activities are “action[s], or series of actions, that [have] a direct impact on safety, quality or efficacy of SoHOs.” This will enable better monitoring of the safety and quality of these products, but it may also require additional investments in IT infrastructure.
Expert insights. Personalized for you.
97 
Let's personalize your content